BRAIN Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 30, 2021)
Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021
This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.
The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.
The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.
What just happenedOct 1, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 30, 2021
- Oct 1, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 30, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 30, 2021IntroReferralB00100
Sponsor introductory remarks on measure. (CR E1050)
- Sep 30, 2021IntroReferralIntro-H
Introduced in House
- Sep 30, 2021IntroReferral1000
Introduced in House